AzTrials
AzTrials

Local Anesthetic EfficacyNCT03342079

Effectiveness of Nitrous Oxide 50% for Reducing Pain and Distress Associated with Needle-stick in Children

A study testing Local Anesthetics,(lidocaine 70 mg/tetracaine 70 mg topical patch; Synera) in people with Local Anesthetic Efficacy, run by Boston Children's Hospital.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Venipuncture (puncturing of a vein) through the skin in order to insert a vein catheter (also know as cannula) is one of the most common needle-related medical procedures performed in children. Read more about this study

Who is it for?
Ages 3 to 6 yearsHealthy volunteers can take part
Conditions the study is for
Local Anesthetic Efficacy
What is being tested?
Local Anesthetics,(lidocaine 70 mg/tetracaine 70 mg topical patch; Synera)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
0 participants
Where
No sites listed yet
Study dates
Mar 2014to Dec 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • • Children ages 3 to 6 years of age who require diagnostic CT or nuclear medicine studies under conscious sedation
  • Guardians give consent and the child gives assent when appropriate
  • Both genders
  • All racial and ethnic groups
  • English and other languages speaking and reading children and guardians (for consent/assent purposes)

Who cannot join

  • Age less than 3 or older than 6 years
  • Patients who had a history of adverse events with facemask; mask phobia
  • If parents/patients refuse to participate in the study
  • Fasting less than 2h for clear liquids, 4h breast milk, 6h formula and fortified breast milk for under 1 yr and 8h for over 1yr, 8h for non-human milk and solid food.
  • Impairment of cognition/neurologic, hepatic, renal, cardiovascular, endocrine, metabolic, and/or coagulation function.
  • A history of any diagnosis of psychiatric disorders as reported by parents/guardians
Show all 13Show fewer
  • A history of chronic pain and/or use of chronic (daily around the clock) opioids, other analgesics or sedatives/hypnotics
  • Intake of prescription medications or over-the-counter medications known to affect pain perception such as narcotics, non-steroidal anti-inflammatory agents, stimulants, hypnotics, sedatives, etc. within 8 hours of planned surgical procedure
  • Vitamin B12 \& folate deficiency
  • Immune suppression (e.g., postoperative organ transplant, chemotherapy, neutropenia, any condition suppresses immunity or bone marrow)
  • Abnormal homocysteine metabolism
  • Lung cyst, bowel obstruction, middle ear disease, pneumothorax, head injury, active gastro-esophageal reflux, history of delayed gastric emptying and vomiting, upper airway obstruction, airway infection, active wheezing from asthma, and apnea
  • Significant impairments: pulmonary hypertensions, cardiomyopathy, hypovolemia, meningitis, space occupying lesions of the brain e.g. tumors, sepsis, severe liver diseases (e.g., biliary atresia, liver failure)

About this study

Official title: Effectiveness of Nitrous Oxide 50% for Reducing Pain and Distress Associated with Needle-stick in Children: a Prospective Randomized Blinded Controlled Trial

Venipuncture (puncturing of a vein) through the skin in order to insert a vein catheter (also know as cannula) is one of the most common needle-related medical procedures performed in children. Venipuncture is necessary for administration of sedation to facilitate motionless patient state for radiological imaging studies such as diagnostic nuclear medicine imaging or CT scan studies.

The current practice for management of needle-related pain is to use needle-less topical local anesthetic delivery systems. These delivery systems are increasingly used in children to anesthetize the skin prior to venipuncture and venous cannulae insertion. This can reduce the pain and distress associated with the needle sticks, however, many children express considerable fear, anxiety and distress during medical procedures that involve needles. Anticipatory pain and phobia associated with needle stick may render the patient uncooperative and anxious even when effective analgesia is produced by a topical local anesthetic.

Read more

Both the discomfort and associated anxiety during such an intervention can be considerably improved when inhaled nitrous oxide is used alone or in combination with local anesthetics. The administration of nitrous oxide (50% to 70%) for painful procedures is an effective and safe method of suppressing procedural pain and distress in children over the age of one year (level 3 evidence). When compared to other intravenous sedation agents, nitrous oxide 50% used for uncomplicated painful procedures is associated with markedly shorter recovery time and less respiratory side effects (level 3 evidence). When combined with local anesthetics for procedural pain and stress management, nitrous oxide 50% is more effective and has higher success rate compared to orally administered anxiolytics or local anesthetic alone (level 2 evidence). Combining nitrous oxide (50-70%) and local anesthetics is shown to be a more effective procedural sedation than local anesthetics alone (level 1 evidence).

The efficacy and safety of inhaled 50-70% nitrous oxide for relief of mild-to-moderate anxiety and pain of venipuncture in children just prior to induction of anesthesia have been investigated in randomized controlled trials by anesthesiologists; physician who are skilled and competent in providing optimal sedation in the operating room setting. The major benefit of administration of a fixed low concentration of 50% nitrous oxide for procedural sedation is that it achieves pain relief while retaining verbal contact with the patient. The efficacy, safety and tolerability of administration of low fixed concentration 50% nitrous oxide using a nitrous oxide mask delivery system for control of mild-to-moderate procedural sedation during performance of needle-related pain (i.e., venipuncture) in children has not been investigated in a blinded randomized controlled trials outside the operating room setting when provided by skilled and competent non-anesthesia trained personnel.

In view of safety of low concentration (50%) of nitrous oxide due to preservation of the patent airway, lack of respiratory depression and rapid recovery, investigators propose this preliminary study to validate the hypothesis that nurse-administered premixed inhaled nitrous oxide and oxygen at a fixed 50:50% concentration with or without a topical anesthetic can provide safe and effective pain relief and reduce behavioral distress in preschool children during routine placement of intravenous cannulation prior to administration of intravenous sedation for nuclear medicine studies and CT imaging studies.

To test this hypothesis, investigators propose performing a prospective, double blind control trial in 105 children undergoing nuclear medicine studies or CT imaging, randomized into three groups;

  1. the treatment groups will receive either nitrous oxide and a placebo topical anesthetic patch or
  2. nitrous oxide and a topical anesthetic patch (Synera) and
  3. the placebo group will receive oxygen mask and a topical anesthetic patch (Synera).

The topical anesthetic patch or placebo patch will be applied for 20 minutes prior to the scheduled insertion of intravenous cannula. The use of a topical local anesthetic such as the Synera patch is a standard of care for placement of intravenous cannula at Children's Hospital Boston.

Assessments to estimate the effectiveness of nitrous oxide with and without the use of topical anesthesia Synera patch will include;

  1. Assessment of child's pain and observer report of pain control.
  2. Child's anxiety before and during the procedure.
  3. Tolerability of the mask delivery system of a fixed concentration of 50% nitrous oxide outside the operating room.
  4. Accuracy of nitrous oxide delivery dose by measuring the end-tidal concentration of nitrous oxide.
  5. Adverse events related to use of nitrous oxide alone or in combination with a topical analgesic.
Read the detailed description

This study was never conducted due to lack of funding

Being tested
Local Anesthetics,(lidocaine 70 mg/tetracaine 70 mg topical patch; Synera), Placebos

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Local Anesthetics,(lidocaine 70 mg/tetracaine 70 mg topical patch; Synera)Drug

    Also called Synera

    topical anesthetic (lidocaine 70 mg/tetracaine 70 mg topical patch; Synera)

  • PlacebosDrug

    Also called Synera patch without local anesthetics

    placebo topical anesthetic

Study groups in NCT03342079
Study groupRoleWhat they receive
Group 1Experimentallocal anesthetic (lidocaine 70 mg/tetracaine 70 mg topical patch; Synera) + placebo
Receives: Drug: Local Anesthetics,(lidocaine 70 mg/tetracaine 70 mg topical patch; Synera); Drug: Placebos
Group 2Experimentallocal anesthetic (lidocaine 70 mg/tetracaine 70 mg topical patch; Synera) + nitrous oxide
Receives: Drug: Local Anesthetics,(lidocaine 70 mg/tetracaine 70 mg topical patch; Synera)
Group 3Placebo comparatorPlacebo + nitrous oxide
Receives: Drug: Placebos

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analgesia measured using the Observational Visual Analog Pain Assessment Scale (0= no pain and 10= unimaginable severe pain)

    decrease pain during venous blood drawing

    Measured: During venipuncture procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2017
  2. Study startMar 2014
  3. Primary completionDec 2014
  4. Study completionDec 2014

Why it stopped: Lack of funding

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03342079
Sponsor's protocol ID
P00002478
Status last verified
Nov 2023
First submitted
12 Jun 2017
Last updated
11 Mar 2025
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Local Anesthetics,(lidocaine 70 mg/tetracaine 70 mg topical patch; Synera) in people with Local Anesthetic Efficacy, run by Boston Children's Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 11 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analgesia measured using the Observational Visual Analog Pain Assessment Scale (0= no pain and 10= unimaginable severe pain) (time frame: During venipuncture procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in